PetMed Express Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $10.84
- Today's High:
- $11.12
- Open Price:
- $11.05
- 52W Low:
- $10.48
- 52W High:
- $21.3747
- Prev. Close:
- $11.04
- Volume:
- 267304
Company Statistics
- Market Cap.:
- $233.71 million
- Book Value:
- 5.819
- Revenue TTM:
- $264.92 million
- Operating Margin TTM:
- -1.24%
- Gross Profit TTM:
- $78.08 million
- Profit Margin:
- -1.29%
- Return on Assets TTM:
- -1.19%
- Return on Equity TTM:
- -2.65%
Company Profile
PetMed Express Inc had its IPO on 1999-04-26 under the ticker symbol PETS.
The company operates in the Healthcare sector and Pharmaceutical Retailers industry. PetMed Express Inc has a staff strength of 302 employees.
Stock update
Shares of PetMed Express Inc opened at $11.05 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $10.84 - $11.12, and closed at $11.
This is a -0.36% slip from the previous day's closing price.
A total volume of 267,304 shares were traded at the close of the day’s session.
In the last one week, shares of PetMed Express Inc have slipped by -4.84%.
PetMed Express Inc's Key Ratios
PetMed Express Inc has a market cap of $233.71 million, indicating a price to book ratio of 2.8636 and a price to sales ratio of 1.5098.
In the last 12-months PetMed Express Inc’s revenue was $264.92 million with a gross profit of $78.08 million and an EBITDA of $934000. The EBITDA ratio measures PetMed Express Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, PetMed Express Inc’s operating margin was -1.24% while its return on assets stood at -1.19% with a return of equity of -2.65%.
In Q2, PetMed Express Inc’s quarterly earnings growth was a negative -58.9% while revenue growth was a positive 11.5%.
PetMed Express Inc’s PE and PEG Ratio
- Forward PE
- 17.9211
- Trailing PE
- 0
- PEG
- 2.58
Its diluted EPS in the last 12-months stands at $-0.17 per share while it has a forward price to earnings multiple of 17.9211 and a PEG multiple of 2.58. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PetMed Express Inc’s profitability.
PetMed Express Inc stock is trading at a EV to sales ratio of 1.1401 and a EV to EBITDA ratio of 13.8048. Its price to sales ratio in the trailing 12-months stood at 1.5098.
PetMed Express Inc stock pays annual dividends of $1.2 per share, indicating a yield of 11.11% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $180.74 million
- Total Liabilities
- $57.32 million
- Operating Cash Flow
- $-37012000.00
- Capital Expenditure
- $1.15 million
- Dividend Payout Ratio
- 0%
PetMed Express Inc ended 2024 with $180.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $180.74 million while shareholder equity stood at $118.32 million.
PetMed Express Inc ended 2024 with $0 in deferred long-term liabilities, $57.32 million in other current liabilities, 21000.00 in common stock, $98.26 million in retained earnings and $20.74 million in goodwill. Its cash balance stood at $61.53 million and cash and short-term investments were $61.53 million. The company’s total short-term debt was $799,000 while long-term debt stood at $0.
PetMed Express Inc’s total current assets stands at $105.83 million while long-term investments were $5.00 million and short-term investments were $0. Its net receivables were $1.89 million compared to accounts payable of $40.04 million and inventory worth $32.32 million.
In 2024, PetMed Express Inc's operating cash flow was $-37012000.00 while its capital expenditure stood at $1.15 million.
Comparatively, PetMed Express Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $11
- 52-Week High
- $21.3747
- 52-Week Low
- $10.48
- Analyst Target Price
- $17.67
PetMed Express Inc stock is currently trading at $11 per share. It touched a 52-week high of $21.3747 and a 52-week low of $21.3747. Analysts tracking the stock have a 12-month average target price of $17.67.
Its 50-day moving average was $12.5 and 200-day moving average was $15.46 The short ratio stood at 7.26 indicating a short percent outstanding of 0%.
Around 407.1% of the company’s stock are held by insiders while 8221.9% are held by institutions.
Frequently Asked Questions About PetMed Express Inc
Similar Industry Stocks (Pharmaceutical Retailers)
Most Active
Top Gainers
Top Losers
About
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.